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Abstract
Background: The Control Preference Scale (CPS) is the most frequently used measure of patients’ preferred roles in
treatment decisions. We revised the original CPS and developed a new computerized patient self-administered version
(eCPS). We used the eCPS to assess role preferences, and their determinants, in Italian and German people with multiple
sclerosis (MS).
Methods: New cartoons were produced, based on MS health professional and patient input/feedback and previous
findings, and pilot tested on 26 Italian and German MS patients. eCPS acceptability and reliability (weighted kappa statistic,
wK) in comparison to the original tool, was determined in 92 MS patients who received both CPS versions in random order.
Results: The new cartoons were well accepted and easily interpreted by patients, who reported they based their choices
mainly on the text and considered the images of secondary importance. eCPS reliability was moderate (wK 0.53, 95%
confidence interval [CI] 0.40–0.65) and similar to the test-retest reliability of face-to-face administration assessed in a
previous publication (wK 0.65, 95% CI 0.45–0.81). Higher education (odds ratio [OR] 3.74, 95% CI 1.00–14.05) and German
nationality (OR 10.30, 95% CI 3.10–34.15) were associated with preference for an active role in the logistic model.
Conclusions: The newly devised eCPS was well received and considered easy to use by MS patients. Reliability was in line
with that of the original version. Role preference appears affected by cultural characteristics and (borderline statistical
significance) education.
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Introduction
Over the last 15 years, initiatives to enhance citizens’ and
patients’ influence in healthcare, and in particular to encourage
shared decision making (SDM), have been proposed. These
initiatives include empowering health providers to inform and
involve patients; providing patient information and decision
support systems [1]; and setting up patient education programs
to prepare them for active involvement in decision-making [2–4].
Nevertheless, implementation of SDM in everyday practice is
hindered by time and budget constraints, and also clinicians’ and
patients’ attitudes, preferences, and expectations. Patient partici-
pation in medical care is generally considered to correlate with
improved health outcomes [5–7]. However, studies indicate that
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while patients want more – and more accurate – information
about their disease, their preferences regarding involvement in
medical decisions vary considerably [8–11].
Therapeutic options for people with multiple sclerosis (PwMS)
have expanded significantly in recent years. Long-term treatment
with first-line ‘disease-modifying’ drugs is increasingly proposed
soon after diagnosis. These treatments are only partially effective
and associated with life-style changes and side effects, resulting in
high dropout rates [12]. More effective and easier to administer
drugs are also available, but these are more costly and associated
with rare but severe side effects [13,14]. For these reasons,
decisions about starting or changing treatments for MS can be
difficult for both patients and physicians, and interventions to
increase patient involvement in decisions about their treatments
and improve MS knowledge, confidence, and satisfaction with the
decision making process have been recently established [13]. In
this context, it is important to elucidate patient preferences
regarding their involvement in decision making. Patient role
preferences may influence the effect of interventions to increase
patient involvement in decision making, while the concordance
between preferred role and actual role can be an outcome measure
of such interventions [15]. Formal assessment of preference is also
important because health professionals have limited ability to
discern or elicit the level of involvement preferred by their
patients, in MS and other medical conditions [16,17]. Finally,
comparison of role preferences across health systems can reveal
cultural differences and provide valuable information for initiatives
to improve patient-clinician communication.
The Control Preference Scale (CPS) is the most frequently used
instrument to assess patient preferences for involvement in
decisions about their health [18,19]. In 2006 we linguistically
validated the Italian CPS, and assessed the preferences of Italian
PwMS. We found that Italian PwMS generally preferred a
collaborative role, while about a third preferred a passive role, and
only about 6% prefer an active role [20]. These findings contrast
markedly with those of a German study which found that 40% of
German PwMS preferred an active role in decision making [21].
In the wake of this surprising finding we initiated the international
project ‘‘Autonomy preferences, risk knowledge and decision-
making performance in multiple sclerosis patients’’ (AutoMS;
www.automsproject.org) to compare patient role preferences and
investigate implementation of the SDM model in six European
countries. It also seemed advisable to develop an electronic self-
administered version of the CPS (eCPS) to standardize test
presentation, eliminate the need for an interviewer and data entry,
and thereby facilitate comparison of CPS performance across
countries. Furthermore, indications from the Italian study [20]
and discussion with the CPS author [18] suggested that the CPS
cartoons would benefit from re-design.
The present paper reports the production of new CPS card
cartoons; the migration of the face-to-face to the electronic version
(eCPS); assessment of the equivalence of the eCPS to the original
test; and prospective evaluation of determinants of role preferences
in Italian and German PwMS.
Methods
Ethics Statement
All the study patients gave written consent to participate. The
protocol was approved by the Ethics Committee of the following
hospitals: Foundation IRCCS Neurological Institute C. Besta,
Milan, Italy; University Medical Center Hamburg-Eppendorf,
Hamburg, Germany; University of Belgrade, Belgrade, Serbia;
National MS-Centrum, Melsbroek, Belgium; Department of
Neurology, West-Tallinn Central Hospital, Tallinn, Estonia;
Department of Neurology, Purpan University Hospital, Toulouse,
France; University ‘‘G. d’Annunzio’’ of Chieti-Pescara, Chieti,
Italy; University of Sassari, Sassari, Italy.
CPS Administration and Scoring
The CPS was developed to evaluate the amount of control
individuals want to assume in decisions regarding their health [18].
It consists of five ‘‘cards’’ on a board, each illustrating a different
role in decision-making by means of a cartoon and short
descriptive statement (Figure 1). The examiner asks the respondent
to choose the preferred card, which is then covered up and cannot
be chosen again; the examiner then asks the respondent to choose
the preferred card from the remaining four cards. The procedure
continues (four choices) until one card is left. If the second
preference is incongruent with the first (non adjacent pairing, such
as card A with card C), the test is explained again, and
immediately re-administered. In the event of a further incongru-
ence, the test is not re-administered, and a preference is not
assigned. Administration requires about 5 min. Six scores are
possible based on the subject’s two most preferred roles: active–
active, active–collaborative, collaborative–active, collaborative–
passive, passive–collaborative, and passive–passive. These scores
are grouped as: active (active–active or active–collaborative),
collaborative (collaborative–active or collaborative–passive), or
passive (passive–collaborative or passive–passive).
Production and Evaluation (Cognitive Debriefing) of New
CPS Cartoons
A professional cartoonist working in medical publishing was
selected from three applicants. A panel consisting of the cartoonist
and the three persons (neurologist, psychologist and lay person)
who had validated the Italian CPS were involved in producing the
new cartoons. At the first panel meeting, the original instrument
and comments of PwMS who took part in the previous study [20]
were presented to the cartoonist and discussed. A month later the
cartoonist submitted her first set of cartoons to a reconvened
meeting. Following discussion, the cartoonist revised the cartoons.
Revisions were presented and re-revised at further meetings until
no further changes were suggested. Finally, the cartoonist further
revised the cartoons taking into account feedback from AutoMS
investigators.
The acceptability and clarity of the ‘‘new’’ CPS (new cartoons
plus original captions) was assessed in a minimum of 10 cognitive
debriefing interviews with Italian and German PwMS aged $18,
with relapsing-remitting course. Patients with exacerbations in the
previous month, definite cognitive compromise, any compromise
precluding participation (e.g. severe visual impairment), or those
who had already received the CPS were ineligible. Each patient
was administered the new CPS. There followed a series of open-
ended questions on the clarity and utility of the instrument as a
whole and each new cartoon, based on an interview guide
previously drawn up and agreed by the German and Italian
investigators. By means of a 0–10 visual analogue scale (VAS),
patients were asked to assess the extent to which the CPS
expressed their attitudes to involvement in decisions (a) on therapy
in general, and (b) on MS immunotherapy.
eCPS Production, Reliability and Usability
The eCPS was designed such that, on a monitor of 15 inches or
more, the electronic cards were similar, in terms of size and color,
to the new CPS cards. The mode of presentation of the electronic
cards and performance of the test matched the original [20]. The
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eCPS test was preceded by a multiple choice socio-demographic
information screen to be completed by the patient; basic clinical
information was subsequently added by the clinician.
The reliability of the eCPS compared to the face-to-face version
was assessed on at least 80 PwMS (Italians and Germans) with
relapsing-remitting MS aged $18 years, excluding those with
exacerbations in the previous month, definite cognitive impair-
ment, and any compromise precluding participation (e.g. severe
visual impairment). One of the tests was given to each patient; the
other test was administered 4–6 weeks later (crossover design,
random test order). This interval was considered long enough to
obviate recall, and short enough so that a change in the patient’s
condition (or role preference) was unlikely (any clinical exacerba-
tions between the two tests were recorded). A sub-sample of 20
patients assigned to receive the eCPS after the original CPS, were
cognitively debriefed immediately after eCPS administration to
obtain feedback on eCPS acceptability and usability, using a
previously drawn up interview guide.
Statistical Analysis
Variables were summarized by means with standard deviation
(SD), or medians with interquartile ranges (IQRs) or ranges.
Categorical variables were compared using the chi-squared test,
and continuous variables using Kruskal–Wallis ANOVA, or
Wilcoxon test for two independent samples. eCPS reliability
(crossover design) was assessed on the six preference categories
with the weighted kappa statistic (wK) with 95% confidence
intervals (CI) estimated by the bootstrap method (5000 replicates).
We used the following weightings: 12|i2j|/(k21), where i and j
index the rows and columns of the ratings at the two
administrations, and k is the maximum number of possible ratings
[22]. We estimated that a minimum of 80 subjects was required to
obtain a kappa value of at least 0.50 (null hypothesis: kappa= 0.30)
under the following assumptions: alpha= 0.05 (two-sided); pow-
er = 0.80; two ratings (tests); six categories with uniform frequency
distribution.
Logistic regression was used to assess the influence of the pre-
specified explanatory variables (age, sex, education, length of
follow-up at participating center, and country) on eCPS active role
preference (vs. collaborative or passive). Continuous variables were
dichotomized with medians as cut-offs. Model goodness-of-fit was
investigated by the Hosmer–Lomeshow test [23]. Results are
reported as odds ratios (OR) with 95% CI. Data were analyzed
using Stata Statistical Software, release 12 (Stata, College Station,
Texas). All tests were two-tailed and p values ,0.05 were
considered significant.
Results
Production and Evaluation (Cognitive Debriefing) of New
CPS Cartoons
The new cartoons were produced between May and September
2010. Unlike the originals they were colored and were also
considered to be more modern (Figure 1). The thought bubbles in
four of the original CPS cards, and the hand-shaking on card C
were no longer present: this rendered the cards more uniform.
Because the new images were more detailed, new problems arose
regarding the gender and age of the patient and the physician, and
the nature of the background. The panel agreed on a female
patient and male physician, and a minimal background compat-
ible with a hospital/outpatient consultation room. A version with
images portraying a male patient was also produced intended for
use in male health conditions (Figure S1).
Figure 1. The five CPS cards with new cartoons.
doi:10.1371/journal.pone.0066127.g001
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After discussion among AutoMS investigators, the following
changes were made: (a) The patient’s expression was changed on
Card A, so that she now appeared less frivolous and to be actively
speaking. (b) Contact between the physician’s hand and patient’s
shoulder was removed from Card E. (c) On card E, the focus was
shifted to the physician instead of the patient, whose back was now
turned, so that this card mirrored card A (where the focus is on the
patient with the physician’s back turned).
Between December 2010 and January 2011, 26 MS patients
received the ‘‘new’’ CPS: 16 were from three Italian tertiary MS
referral centers, and 10 from the Hamburg outpatient MS clinic.
Twelve (46%) were women; median age was 37 years; median
disease duration was 9.3 years; and median EDSS score 2.5
(Table 1). Three Italian MS patients gave incongruent answers on
both the first and second administration, so CPS scores were not
obtained. CPS scores were therefore available for 23 (88%)
participants: 10 (44%) preferred a collaborative role; 9 (39%) an
active role; and 4 (17%) a passive role. Role preference differed
significantly between countries, with active/collaborative/passive
roles reported by 15%/55%/30% of Italian vs. 70%/30%/0% of
German patients (p = 0.016).
In general, the cartoons were well received and considered
clear, but almost all patients considered they had a minor role
compared to the text, indicating that their choice was mainly
based on the text: ‘‘You could have omitted the cartoons. They are
nice but not enough on their own to allocate role preference’’
[German patient]; ‘‘They [the images] are a nice accompaniment,
they don’t distract; they remind me of children’s books’’ [Italian
patient]; ‘‘I didn’t mind the pictures; they didn’t distract me from
the text… they are appealing and appropriate’’ [German patient];
‘‘I just used the text. The pictures were secondary, not to be taken
seriously, I could have read a comic instead… They are
interchangeable’’ [German patient].
All patients reported that it was easy for them to pick one of the
five cards that best described their preference. One Italian patient
commented that, by choosing more than one card, the patient
strengthens the first choice with the second.
Patients assigned a median VAS score of 8.0 (IQR 7.5–9.0) for
the extent to which the CPS expressed their attitude to
involvement in decisions about therapy in general. The VAS
score for involvement in decisions on immunotherapy was 9.0
(IQR 8.0–9.0). Regarding the issue of acceptability, considering
that the patient in the cartoons was a woman, a male patient found
this acceptable as the ‘‘woman with MS has to do with disease
statistics’’; the other patients reported that they did not notice or
were not bothered.
eCPS Production, Reliability and Usability Testing
Between October 2010 and May 2011, the electronic version
was produced in English, German and Italian, and the screens for
recording responders’ socio-demographic and basic clinical
information inserted.
Between August 2011 and March 2012, 92 MS patients, 54 in
Italy, and 38 in Germany (Table 1) participated in the crossover
study. Four participants (three Italian) gave incongruent answers,
and one Italian patient did not perform the second test: Full CPS
scores were therefore available for 87 (95%).
Median test-retest interval was of 4 weeks in Germany and 5
weeks in Italy. In Germany there were three protocol violations
(patients on steroids for an exacerbation at enrolment); these were
included in the analysis. Of the included patients, 71 (83%) used a
computer more than once a week, and 63 (72%) had internet at
home.
Rolepreferencesbyadministration (face-to-facevs. electronic)and
country are shown in Figure 2. The reliability of the eCPS in relation
to the face-to-faceCPSwasmoderate: observedagreementwas85%,
wK0.53 (95%CI0.40–0.65;p,0.001).These findingsare consistent
with the test-retest reliability of the face-to-faceCPSobtained in Italy
(observed agreement 90%; wK 0.65 [95%CI 0.45–0.81]; p,0.001)
[20]. Five participants did the eCPS test twice because of inconsistent
choices, two of the five made inconsistent choices at second
administration (invalid test). Two participants did the face-to-face
CPS twice for the same reason, andbothmade inconsistent choices at
second administration.
From interviews with 43 patients who received the eCPS after
the face-to-face version, the tool was found to be well accepted by
41 (95%) and considered useful by 39 (90%). Twenty-two patients
(51%) said they based their choice on the text only, 14 (32%)
mainly on the text, and 7 (16%) on both text and images. With
regard to eCPS usability, 39 (90%) considered the instructions easy
to understand and the overall procedure user-friendly: one 33
year-old man with tremor had difficulty using the mouse; two
women (of 55 and 37 years, both with elementary education and
unfamiliar with a computer) had some difficulties navigating.
Patients assigned a median VAS of 8.0 (IQR 7.0–9.0) to the
extent to which the CPS expressed their attitudes to involvement
in decisions both about therapy in general and about immuno-
therapy.
Role Preference Across Countries
We used logistic regression to assess factors associated with
active role preference (Table 2). German PwMS were seven times
more likely to prefer an active role than Italians (OR 6.89, 95% CI
2.54–18.68). This association was strengthened (OR 10.30, 95%
CI 3.10–34.15) after controlling for gender, age, education and
length of follow-up at the MS center. Higher education was
positively associated with active role preference (OR 3.75, 95% CI
1.00–14.05). Length of follow-up at the MS center for five years or
more was negatively associated with active role preference in the
univariate analysis (OR 0.35, 95% CI 0.13–0.93), but this
association was no longer significant after controlling for the other
explanatory variables (Table 2). Neither gender nor age were
associated with active role preference.
Discussion
When a qualitative approach is not feasible, the CPS is useful to
assess the role preferences of patients and citizens in large-scale
studies [24]. Administering the CPS on a computer improves the
standardization of test presentation and reduces investigator
involvement. However, eCPS equivalence with the original
version and receiver acceptability require careful assessment.
Recently, both computerized and video CPS versions have been
used in patients with prostate cancer [25–27]. The video CPS
proved feasible and acceptable [28], but the equivalence of these
new versions with the original test was not investigated.
We found that both Italian and German MS patients received
the eCPS well and found the instrument easy to understand. In
our crossover sub-study, concordance of the eCPS with the face-
to-face version was moderate, and in the same range as the test-
retest reliability of the original version [20], indicating that
concordance was unaffected by mode of administration, and
supporting the equivalence of the eCPS with the original test [29].
Test usability was very good, with all participants completing both
the questionnaire on the opening screen and the eCPS test, about
a quarter of whom only had elementary education, while 12%
used the computer rarely or not at all. Both Italian and German
Role Preferences in Multiple Sclerosis
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participants based their choices mainly on the text and considered
the images of secondary importance. Opinions differed, however,
about the utility of the images: Italians were more positive about
them, suggesting they complemented the text, while Germans
were less enthusiastic, some regarding them as superfluous or
irrelevant.
In line with our previous findings, we found a marked difference
between Italian and German participants with respect to decision-
making preference, in that German MS patients wanted a more
active role [20,21]. Importantly, this finding was independent of
gender, age, education and length of follow-up at the MS center.
In agreement with studies in other health contexts, well educated
participants were also more likely to prefer an active role in the
multivariate model (borderline significance) [8,9,30], suggesting
that education facilitates patient empowerment. In contrast to
findings that women and younger people generally prefer a more
active role [8,10], neither gender nor age had an influence on role
preference in our study.
The fact that Italian PwMS prefer a collaborative or passive
decisional role is not at odds with their wish to be more informed
about their disease from the moment of diagnosis communication
[31]. Other studies also indicate that while patients want more –
and more accurate – information about their disease, their
preferences regarding involvement in medical decisions vary
considerably [8,30].
Data from all six countries participating in AutoMS are
currently being collected: preliminary findings that include data
from Serbia and Estonia confirm that German PwMS significantly
prefer an active role, while Serbian and Estonian participants do
not differ significantly from each other or Italy (reference) (data not
shown). Country-specific variations in health system organization
might contribute to these differences; in particular it is known that
recommendations on patient and citizen empowerment started
Table 1. Characteristics of the patients participating in the two study phases.
Characteristic Sub-characteristic Phase I: new cartoons Phase II: eCPS reliability
Germany (N=10) Italy (N=16) Germany (N=38) Italy (N=54)
Women (%) 3 (30) 8 (50) 26 (68) 33 (61)
Age (years)1 42, 12 (26–63) 36, 7 (27–48) 39, 10 (18–62) 38, 9 (19–55)
Time from first symptoms (%) #5 years 0 (0) 0 (0) 13 (34) 19 (35)
.5 years 10 (100) 16 (100) 25 (66) 35 (65)
Setting (%) Outpatient clinic 0 9 (60) 26 (68) 25 (46)
Day-Hospital 10 (100) 6 (40) 12 (32) 29 (54)
Education (%) Primary (5–10 y) 2 (20) 3 (19) 15 (39) 10 (19)
Secondary (11–13 y) 4 (40) 4 (25) 9 (24) 29 (53)
College/University ($14 y) 4 (40) 9 (56) 14 (37) 15 (28)
Work (%) Employed full-time 5 (50) 10 (62) 12 (31) 31 (57)
Employed part-time 1 (10) 0 5 (13) 4 (7)
Unemployed 0 2 (12) 5 (13) 5 (9)
Student 1 (10) 2 (12) 3 (8) 3 (6)
Homemaker 1 (10) 1 (6) 3 (8) 5 (9)
Retired 0 0 1 (3) 0
Disability-support pension 2 (20) 1 (6) 9 (24) 6 (12)
EDSS score2 3.0 (0.0–6.0) 2.2 (0.5–6.0) 3.0 (2.5–4.0) 2.0 (0.0–6.5)
Disease-modifying treatment (%) Interferons 0 6 (37) 2 (7) 4 (9)
Glatiramer acetate 0 4 (25) 1 (4) 14 (31)
Natalizumab 3 (30) 5 (31) 25 (89) 20 (43)
Immunosuppressants 2 (20) 0 0 8 (17)
Followed at MS center (%) ,1 year 5 (50) 3 (19) 9 (24) 5 (10)
1–5 years 4 (40) 3 (19) 19 (50) 19 (35)
.5 years 1 (10) 10 (62) 10 (26) 30 (55)
Use of computer3 No NA NA 0 5 (10)
Rare (less than once a week) 2 (6) 4 (8)
Moderate (about weekly) 2 (6) 2 (4)
Frequent (more than weekly) 32 (89) 39 (78)
Test-retest interval (days)2 NA NA 28 (14–56) 34 (23–59)
CPS is Control preference Scale; EDSS is Expanded Disability Status Scale; NA is not applicable.
1Mean, SD (range).
2Median (range).
3Missing information: n = 2 Germany; n = 4 Italy.
doi:10.1371/journal.pone.0066127.t001
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Figure 2. Distribution of role preferences according to administered CPS (face-to-face vs. electronic, eCPS) in 87 MS patients. CPS
scores range from 1 (active-active) through 6 (passive-passive). The histograms report numbers of patients with each CPS score, by country (Italy,
black; Germany, grey). The bubble plot shows pairs of counts of each score, with larger bubbles corresponding to higher counts.
doi:10.1371/journal.pone.0066127.g002
Table 2. Variables associated with active role preference on the eCPS among 87 people with MS in univariate and multivariate
models. Age was categorized into two classes, with median as cutoff.
Characteristic Sub-characteristic






Age (years) ,38 44, 16 (36.4) 1 0.54 1 0.87
$38 43, 13 (30.2) 0.76 (0.31–1.86) 0.91 (0.31–2.72)
Sex Men 30, 11 (36.7) 1 0.63 1 0.35
Women 57, 18 (31.6) 0.80 (0.31–2.02) 0.59 (0.20–1.78)
Education Primary 22, 6 (27.3) 1 0.48 1 0.05
Secondary or higher 65, 23 (35.4) 1.46 (0.50–4.24) 3.75 (1.00–14.05)
Followed at the MS center #5 years 49, 21 (42.9) 1 0.03 1 0.39
.5 years 38, 8 (21.1) 0.35 (0.13–0.93) 0.61 (0.19–1.88)
Country Italy 50, 8 (16.0) 1 ,0.001 1 ,0.001
Germany 37, 21 (56.8) 6.89 (2.54–18.68) 10.30 (3.10–34.15)
OR is odds ratio, and 95% CI the OR confidence interval, estimated by unconditional logistic-regression.
Multivariate model including all explanatory variables, with Hosmer-Lemshow goodness-of-fit test x2 = 7.7 (degrees of freedom=22), p= 0.47.
doi:10.1371/journal.pone.0066127.t002
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being implemented earlier in Germany than other European
countries [2–4]. However, discerning the influences of health
system characteristics and SDM promotion initiatives is not
straightforward [5]. Moreover, social and policy changes can take
time to affect everyday practice, as shown by a recent study
showing that, more than 20 years after unification, people in
former Eastern Germany prefer more passive roles than those
living in Western Germany [32]. A recently published study in
Hispanic patients with advanced cancer found that preference for
a passive role was four-fold higher in those living in Latin America
compared to those living in the US, after controlling for age and
education [33].
Our study was confined to patients with MS, most of whom
were young females (typical of the condition): our findings are
therefore unlikely to be applicable to other illnesses or populations.
In addition, while the Italian participants were from three
geographically disparate areas (Northern, Central and Southern
Italy) the German participants were all from the area of Hamburg
which may not be representative of Germany as a whole.
Another limitation is that we did not take account of other
characteristics that may influence variation in patient decision-
making preferences, such as socio-economic status, depressive
symptoms, proximity to the decision about whether to start or
change immunotherapy, and theory-based behavioural measures
[34,35]. In this regard, we have recently devised a patient
questionnaire on MS immunotherapy decision making, based on
the theory of planned behaviour [36]. This questionnaire has been
translated and culturally adapted into the AutoMS languages
(paper in preparation) and will be used as moderator of role
preferences (assessed with the eCPS) in an international online
survey of PwMS considering whether to start or change
immunotherapy.
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